Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Henriksen

Showing results (21-30 of 154) with videos related to

Pageof 16
Sort By:
Journal of Cardiovascular Pharmacology|February 11, 2025
Decastatin, a Novel Non-Collagenous 1 Domain From Collagen Type X, Harbors a Specific Fragment With Antiangiogenic PropertiesStine Marie Jansen, Rastislav Pitek, Morten Asser Karsdal, et al.
The Journal of Biological Chemistry|September 25, 2003
RANKL and vascular endothelial growth factor (VEGF) induce osteoclast chemotaxis through an ERK1/2-dependent mechanismKim Henriksen, Morten Karsdal, Jean-Marie Delaisse, et al.
Expert Opinion on Biological Therapy|October 12, 2010
Oral salmon calcitonin--pharmacology in osteoporosisKim Henriksen, Anne-Christine Bay-Jensen, Claus Christiansen, et al.
British Journal of Pharmacology|February 20, 2024
Are insulin sensitizers the new strategy to treat Type 1 diabetes? A long-acting dual amylin and calcitonin receptor agonist improves insulin-mediated glycaemic control and controls body weightSimone Anna Melander, Anna Thorsø Larsen, Morten Asser Karsdal, et al.
European Journal of Endocrinology|June 8, 2013
Autosomal dominant osteopetrosis revisited: lessons from recent studiesJens Bollerslev, Kim Henriksen, Morten Frost Nielsen, et al.
Journal of Clinical Pharmacology|January 31, 2009
A pharmacokinetic and pharmacodynamic comparison of synthetic and recombinant oral salmon calcitoninMorten A Karsdal, Inger Byrjalsen, Kim Henriksen, et al.
Human Gene Therapy|June 11, 2019
Hematopoietic Stem Cell-Targeted Neonatal Gene Therapy with a Clinically Applicable Lentiviral Vector Corrects Osteopetrosis in <i>oc/oc</i> MiceHenrik Löfvall, Michael Rothe, Axel Schambach, et al.
Bone|April 7, 2009
Local communication on and within bone controls bone remodelingKim Henriksen, Anita V Neutzsky-Wulff, Lynda F Bonewald, et al.
Frontiers in Neurology|June 2, 2015
The potential of pathological protein fragmentation in blood-based biomarker development for dementia - with emphasis on Alzheimer's diseaseDilek Inekci, Ditte Svendsen Jonesco, Sophie Kennard, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 2, 2011
Generation of human osteoclasts from peripheral bloodKim Henriksen, Morten A Karsdal, Adam Taylor, et al.
Pageof 16

Showing results (21-30 of 154) with videos related to

Sort By:
Pageof 16
Journal of Cardiovascular Pharmacology|February 11, 2025
Decastatin, a Novel Non-Collagenous 1 Domain From Collagen Type X, Harbors a Specific Fragment With Antiangiogenic PropertiesStine Marie Jansen, Rastislav Pitek, Morten Asser Karsdal, et al.
The Journal of Biological Chemistry|September 25, 2003
RANKL and vascular endothelial growth factor (VEGF) induce osteoclast chemotaxis through an ERK1/2-dependent mechanismKim Henriksen, Morten Karsdal, Jean-Marie Delaisse, et al.
Expert Opinion on Biological Therapy|October 12, 2010
Oral salmon calcitonin--pharmacology in osteoporosisKim Henriksen, Anne-Christine Bay-Jensen, Claus Christiansen, et al.
British Journal of Pharmacology|February 20, 2024
Are insulin sensitizers the new strategy to treat Type 1 diabetes? A long-acting dual amylin and calcitonin receptor agonist improves insulin-mediated glycaemic control and controls body weightSimone Anna Melander, Anna Thorsø Larsen, Morten Asser Karsdal, et al.
European Journal of Endocrinology|June 8, 2013
Autosomal dominant osteopetrosis revisited: lessons from recent studiesJens Bollerslev, Kim Henriksen, Morten Frost Nielsen, et al.
Journal of Clinical Pharmacology|January 31, 2009
A pharmacokinetic and pharmacodynamic comparison of synthetic and recombinant oral salmon calcitoninMorten A Karsdal, Inger Byrjalsen, Kim Henriksen, et al.
Human Gene Therapy|June 11, 2019
Hematopoietic Stem Cell-Targeted Neonatal Gene Therapy with a Clinically Applicable Lentiviral Vector Corrects Osteopetrosis in <i>oc/oc</i> MiceHenrik Löfvall, Michael Rothe, Axel Schambach, et al.
Bone|April 7, 2009
Local communication on and within bone controls bone remodelingKim Henriksen, Anita V Neutzsky-Wulff, Lynda F Bonewald, et al.
Frontiers in Neurology|June 2, 2015
The potential of pathological protein fragmentation in blood-based biomarker development for dementia - with emphasis on Alzheimer's diseaseDilek Inekci, Ditte Svendsen Jonesco, Sophie Kennard, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 2, 2011
Generation of human osteoclasts from peripheral bloodKim Henriksen, Morten A Karsdal, Adam Taylor, et al.
Pageof 16